Projection-bearing body manufacturing method and projection-bearing body manufacturing device
US-2024001625-A1 · Jan 4, 2024 · US
US9522502B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9522502-B2 |
| Application number | US-201414512839-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 13, 2014 |
| Priority date | Sep 28, 2010 |
| Publication date | Dec 20, 2016 |
| Grant date | Dec 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present specification discloses porous materials, methods of forming such porous materials, materials and devices comprising such porous materials, and methods of making such materials and devices.
Opening claim text (preview).
What is claimed is: 1. A method for forming an elastic, porous structure suitable for implantation in a mammal, the method comprising the steps of: a) coating porogens with a matrix material to form a matrix material-coated porogen mixture, wherein the matrix material is a poly(lactic-co-glycolic acid) (PLGA); b) filtering the matrix material-coated porogen mixture through a sieve to remove excess matrix material; c) pouring the filtered mixture into a mold; d) treating the filtered mixture to form a scaffold comprising fused porogens and cured matrix material, wherein the scaffold comprises a three-dimensional structure in the form of the mold; and e) removing the fused porogens from the scaffold, wherein fused porogen removal results in a porous material comprising the cured matrix material defining an array of interconnected pores. 2. The method of claim 1 , wherein in the scaffold comprises a three-dimensional structure wherein the diameter of substantially all the connections between each fused porogen in between about 15% to about 80% of the mean porogen diameter. 3. The method of claim 1 , wherein the cured matrix material exhibits an elastic elongation of at least 80%. 4. The method of claim 1 , wherein the matrix material is a silicone elastomer. 5. The method of claim 1 , wherein the porogens are porogens having a diameter of 50 μm to about 3000 μm. 6. The method of claim 1 , wherein the porogens are porogens having a diameter of about 500 μm. 7. The method of claim 1 , wherein the porogens are porogens having a diameter of about 650 μm. 8. A method for forming a tissue engineering scaffold suitable for implantation in a mammal, the method comprising the steps of: a) coating porogens with a matrix material to form a matrix material-coated porogen mixture, wherein the porogens are porogens having a diameter of 50 μm to about 3000 μm; b) filtering the matrix material-coated porogen mixture through a sieve to remove excess matrix material; c) pouring the filtered mixture into a mold; d) treating the filtered mixture to form a scaffold comprising fused porogens and cured matrix material, wherein the scaffold comprises a three-dimensional structure in the form of the mold; and e) removing the fused porogens from the scaffold, wherein fused porogen removal results in a porous material comprising the cured matrix material defining an array of interconnected pores. 9. The method of claim 8 , wherein in the scaffold comprises a three-dimensional structure wherein the diameter of substantially all the connections between each fused porogen in between about 15% to about 80% of the mean porogen diameter. 10. The method of claim 8 , wherein the cured matrix material exhibits an elastic elongation of at least 80%. 11. The method of claim 8 , wherein the matrix material is a silicone elastomer. 12. The method of claim 8 , wherein the matrix material is a poly(lactic-co-glycolic acid) (PLGA). 13. The method of claim 8 , wherein the porogens are porogens having a diameter of about 500 μm. 14. The method of claim 8 , wherein the porogens are porogens having a diameter of about 650 μm. 15. A method for forming an elastic porous article for biomedical applications, the method comprising the steps of: a) coating porogens with a matrix material to form a matrix material-coated porogen mixture, wherein the porogens are porogens having a diameter of 50 μm to about 3000 μm; b) filtering the matrix material-coated porogen mixture through a sieve to remove excess matrix material; c) pouring the filtered mixture into a mold; d) treating the filtered mixture to form a scaffold comprising fused porogens and cured matrix material, wherein the scaffold comprises a three-dimensional structure in the form of the mold; and e) removing the fused porogens from the scaffold, wherein fused porogen removal results in a porous material comprising the cured matrix material defining an array of interconnected pores. 16. The method of claim 15 , wherein the porous article is a membrane for filtration or separation. 17. The method of claim 15 , wherein the porous article is a wound dressing. 18. The method of claim 15 , wherein the porous article is a drug release matrix.
comprising elimination of a solid or a liquid ingredient · CPC title
Copolymers · CPC title
Web or sheet containing structurally defined element or component · CPC title
using organic solvents · CPC title
Polysiloxanes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.